|
|
|
|
LEADER |
03388nam a2200517Ia 4500 |
001 |
10-1017-S1355617721000084 |
008 |
220420s2022 CNT 000 0 und d |
020 |
|
|
|a 13556177 (ISSN)
|
245 |
1 |
0 |
|a Validation and Normative Data of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME)
|
260 |
|
0 |
|b Cambridge University Press
|c 2022
|
300 |
|
|
|a 11
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1017/S1355617721000084
|
520 |
3 |
|
|a Objective: The relevance of the episodic memory in the prediction of brain aging is well known. The Face Name Associative Memory Exam (FNAME) is a valued associative memory measure related to Alzheimer's disease (AD) biomarkers, such as amyloid-β deposition preclinical AD individuals. Previous validation of the Spanish version of the FNAME test (S-FNAME) provided normative data and psychometric characteristics. The study was limited to subjects attending a memory clinic and included a reduced sample with gender inequality distribution. The purpose of this study was to assess S-FNAME psychometric properties and provide normative data in a larger independent sample of cognitively healthy individuals. Method: S-FNAME was administered to 511 cognitively healthy volunteers (242 women, aged 41-65 years) participating in the Barcelona Brain Health Initiative cohort study. Results: Factor analysis supported construct validity revealing two underlying components: face-name and face-occupation and explaining 95.34% of the total variance, with satisfactory goodness of fit. Correlations between S-FNAME and Rey Auditory-Verbal Learning Test were statistically significant and confirmed its convergent validity. We also found weak correlations with non-memory tests supporting divergent validity. Women showed better scores, and S-FNAME was positively correlated with education and negatively with age. Finally, we generated normative data. Conclusions: The S-FNAME test exhibits good psychometric properties, consistent with previous findings, resulting in a valid and reliable tool to assess episodic memory in cognitively healthy middle-aged adults. It is a promising test for the early detection of subtle memory dysfunction associated with abnormal brain aging. © INS. Published by Cambridge University Press, 2021.
|
650 |
0 |
4 |
|a adult
|
650 |
0 |
4 |
|a Adult
|
650 |
0 |
4 |
|a Alzheimer disease
|
650 |
0 |
4 |
|a Alzheimer Disease
|
650 |
0 |
4 |
|a Alzheimer's disease
|
650 |
0 |
4 |
|a cognitive aging
|
650 |
0 |
4 |
|a cohort analysis
|
650 |
0 |
4 |
|a Cohort Studies
|
650 |
0 |
4 |
|a Episodic memory
|
650 |
0 |
4 |
|a female
|
650 |
0 |
4 |
|a Female
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a Humans
|
650 |
0 |
4 |
|a memory
|
650 |
0 |
4 |
|a Memory
|
650 |
0 |
4 |
|a memory and learning test
|
650 |
0 |
4 |
|a middle aged
|
650 |
0 |
4 |
|a Middle Aged
|
650 |
0 |
4 |
|a Names
|
650 |
0 |
4 |
|a neuropsychologic test
|
650 |
0 |
4 |
|a neuropsychological test
|
650 |
0 |
4 |
|a Neuropsychological Tests
|
650 |
0 |
4 |
|a nomenclature
|
650 |
0 |
4 |
|a validation study
|
700 |
1 |
0 |
|a Alegret, M.
|e author
|
700 |
1 |
0 |
|a Alviarez-Schulze, V.
|e author
|
700 |
1 |
0 |
|a Bartrés-Faz, D.
|e author
|
700 |
1 |
0 |
|a Cattaneo, G.
|e author
|
700 |
1 |
0 |
|a Pachón-García, C.
|e author
|
700 |
1 |
0 |
|a Pascual-Leone, A.
|e author
|
700 |
1 |
0 |
|a Solana-Sánchez, J.
|e author
|
700 |
1 |
0 |
|a Tormos-Muñoz, J.M.
|e author
|
773 |
|
|
|t Journal of the International Neuropsychological Society
|